Molecular Insight Pharmaceuticals, Inc. 4
4 · Molecular Insight Pharmaceuticals, Inc. · Filed Dec 4, 2007
Insider Transaction Report
Form 4
Babich John W
DirectorPresident, CEO and CSO
Transactions
- Purchase
Common Stock
2007-11-30$8.34/sh+600$5,004→ 171,635 total - Purchase
Common Stock
2007-11-30$8.35/sh+1,900$15,865→ 173,535 total